• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新冠疫苗接种后出现急性甲状腺肿大伴严重甲状腺功能减退性黏液水肿

Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination.

作者信息

Giusti Massimo, Maio Agostino

机构信息

BIOMEDICAL Genoa Italy.

ASL 3 Genovese Genoa Italy.

出版信息

Clin Case Rep. 2021 Dec 13;9(12):e05217. doi: 10.1002/ccr3.5217. eCollection 2021 Dec.

DOI:10.1002/ccr3.5217
PMID:34938565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667292/
Abstract

The SARS-CoV-2 virus can trigger thyroid dysfunction. Thyroid dysfunctions after COVID-19 vaccination have been rarely reported. We report the case of overt hypothyroidism in a 61-year-old woman seen after BNT162b2-mRNA vaccination. This case underlines the fact that thyroid function should also be monitored after COVID-19 vaccination, especially in at-risk subjects.

摘要

严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒可引发甲状腺功能障碍。新冠病毒疾病（COVID-19）疫苗接种后出现甲状腺功能障碍的情况鲜有报道。我们报告了1例61岁女性在接种BNT162b2信使核糖核酸（mRNA）疫苗后出现明显甲状腺功能减退的病例。该病例凸显了在COVID-19疫苗接种后也应监测甲状腺功能这一事实，尤其是在高危人群中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329e/8667292/0f224bb8d14a/CCR3-9-e05217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329e/8667292/0f224bb8d14a/CCR3-9-e05217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329e/8667292/0f224bb8d14a/CCR3-9-e05217-g001.jpg

相似文献

1
Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination.新冠疫苗接种后出现急性甲状腺肿大伴严重甲状腺功能减退性黏液水肿
Clin Case Rep. 2021 Dec 13;9(12):e05217. doi: 10.1002/ccr3.5217. eCollection 2021 Dec.
2
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.接种 SARS-CoV-2 mRNA 疫苗后 Graves 病的发病：病例报告及文献复习。
Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021.
3
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients.mRNA 和灭活 COVID-19 疫苗相关甲状腺功能障碍的风险：一项 230 万疫苗接种者的基于人群的研究。
BMC Med. 2022 Oct 14;20(1):339. doi: 10.1186/s12916-022-02548-1.
4
Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.甲状腺功能减退症患者接种灭活新冠疫苗和 mRNA 新冠疫苗的安全性：一项基于人群的队列研究。
Thyroid. 2022 May;32(5):505-514. doi: 10.1089/thy.2021.0684. Epub 2022 Apr 7.
5
HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.接种 SARS-CoV-2 疫苗后发生亚急性甲状腺炎和格雷夫斯病的患者的 HLA 分型：病例报告。
BMC Endocr Disord. 2023 Mar 7;23(1):54. doi: 10.1186/s12902-023-01287-5.
6
Overt Hypothyroidism Status Post Pfizer-BioNTech Vaccination: A Case Study.辉瑞-生物科技公司疫苗接种后出现明显甲状腺功能减退：病例研究
Cureus. 2023 Jun 30;15(6):e41180. doi: 10.7759/cureus.41180. eCollection 2023 Jun.
7
Laryngeal myxoedema: a literature review of an uncommon complication of hypothyroidism.喉黏液性水肿：甲状腺功能减退症一种罕见并发症的文献综述
BMJ Case Rep. 2021 Apr 1;14(4):e241313. doi: 10.1136/bcr-2020-241313.
8
Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study.自身免疫性甲状腺炎患者对 COVID-19 BNT162b2 mRNA 疫苗的免疫反应与健康受试者相似，而接种疫苗可能会影响甲状腺功能：一项临床研究。
Front Endocrinol (Lausanne). 2022 Feb 22;13:840668. doi: 10.3389/fendo.2022.840668. eCollection 2022.
9
Myxoedema coma caused by immunotherapy-related thyroiditis and enteritis.免疫疗法相关的甲状腺炎和肠炎所致黏液性水肿昏迷。
Endocrinol Diabetes Metab Case Rep. 2021 Oct 1;2021. doi: 10.1530/EDM-21-0130.
10
Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence.接种 COVID-19 疫苗后甲状腺功能障碍：初步证据的基础综述。
J Endocrinol Invest. 2022 Oct;45(10):1835-1863. doi: 10.1007/s40618-022-01786-7. Epub 2022 Mar 26.

引用本文的文献

1
Overt Hypothyroidism Status Post Pfizer-BioNTech Vaccination: A Case Study.辉瑞-生物科技公司疫苗接种后出现明显甲状腺功能减退：病例研究
Cureus. 2023 Jun 30;15(6):e41180. doi: 10.7759/cureus.41180. eCollection 2023 Jun.
2
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): past, present, and future implications.佐剂诱发的自身免疫/炎症综合征（ASIA）：过去、现在和未来的意义。
Clin Exp Immunol. 2023 Jul 5;213(1):87-101. doi: 10.1093/cei/uxad033.
3
Vaccines and Autoimmunity-From Side Effects to ASIA Syndrome.疫苗与自身免疫病：从副作用到 ASIA 综合征

本文引用的文献

1
Long-term Observation of Thyroid Volume Changes in Hashimoto's Thyroiditis in a Series of Women on or off Levo-Thyroxine Treatment in an Area of Moderate Iodine Sufficiency.在碘摄入适量地区，对一系列接受或未接受左甲状腺素治疗的桥本甲状腺炎女性患者甲状腺体积变化的长期观察
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(1):131-136. doi: 10.4183/aeb.2021.131.
2
Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).接种新型冠状病毒肺炎（COVID-19）腺病毒载体疫苗后发生的亚急性甲状腺炎
Cureus. 2021 Jun 29;13(6):e16045. doi: 10.7759/cureus.16045. eCollection 2021 Jun.
3
Myxedema Coma: Case Report and Literature Review.
Medicina (Kaunas). 2023 Feb 14;59(2):364. doi: 10.3390/medicina59020364.
4
Retrospective observation of subacute thyroiditis before and during the COVID-19 vaccination campaign in a single secondary endocrine centre in the Savona district, Liguria, Italy.意大利利古里亚大区萨沃纳市一家二级内分泌中心对新冠疫苗接种活动之前及期间的亚急性甲状腺炎进行的回顾性观察。
Thyroid Res. 2022 Nov 2;15(1):21. doi: 10.1186/s13044-022-00139-z.
5
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients.mRNA 和灭活 COVID-19 疫苗相关甲状腺功能障碍的风险：一项 230 万疫苗接种者的基于人群的研究。
BMC Med. 2022 Oct 14;20(1):339. doi: 10.1186/s12916-022-02548-1.
6
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.甲状腺与接种 SARS-CoV-2 疫苗的不适反应：问题的大小。系统综述。
Front Endocrinol (Lausanne). 2022 Jun 23;13:900964. doi: 10.3389/fendo.2022.900964. eCollection 2022.
7
Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence.接种 COVID-19 疫苗后甲状腺功能障碍：初步证据的基础综述。
J Endocrinol Invest. 2022 Oct;45(10):1835-1863. doi: 10.1007/s40618-022-01786-7. Epub 2022 Mar 26.
黏液性水肿昏迷：病例报告及文献综述
Cureus. 2021 May 27;13(5):e15277. doi: 10.7759/cureus.15277.
4
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
5
Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.新型冠状病毒肺炎疫苗接种与面神经麻痹的相关性：一项病例对照研究。
JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):739-743. doi: 10.1001/jamaoto.2021.1259.
6
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎：疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
7
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
8
Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants.两例接种 SARS-CoV-2 疫苗后发生的 Graves 病：佐剂诱导的自身免疫/炎症综合征。
Thyroid. 2021 Sep;31(9):1436-1439. doi: 10.1089/thy.2021.0142. Epub 2021 May 3.
9
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.人源单克隆抗体对 SARS-CoV-2 蛋白与组织抗原的反应：对自身免疫性疾病的影响。
Front Immunol. 2021 Jan 19;11:617089. doi: 10.3389/fimmu.2020.617089. eCollection 2020.
10
Normal thyroid volume in subjects evaluated in a primary ambulatory setting in Liguria.在利古里亚的初级门诊环境中评估的受试者的正常甲状腺体积。
Minerva Endocrinol (Torino). 2023 Mar;48(1):19-26. doi: 10.23736/S2724-6507.20.03312-X. Epub 2021 Jan 12.